• OPEN AN ACCOUNT
Indian Indices
Sensex
74,729.27 413.66
( 0.56%)
Global Indices
Nasdaq
52,025.19 -173.50
(-0.33%)
Dow Jones
7,682.22 -82.84
(-1.07%)
Hang Seng
65,489.63 1,063.68
(1.65%)
Nikkei 225
10,879.96 39.61
(0.37%)
Forex
USD-INR
94.85 -0.23
(-0.24%)
EUR-INR
106.35 0.11
(0.11%)
GBP-INR
125.73 -0.01
(-0.01%)
JPY-INR
0.60 0.00
(0.07%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
276.4035981
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
48.95
1180.76
EPS(TTM)
Face Value()
Div & Yield %
20.47
10
0.05
 

restaurant br&s asia ltd
Stylam Industries consolidated net profit rises 29.31% in the March 2026 quarter
May 07,2026
Net profit of Stylam Industries rose 29.31% to Rs 38.25 crore in the quarter ended March 2026 as against Rs 29.58 crore during the previous quarter ended March 2025. Sales rose 6.66% to Rs 282.95 crore in the quarter ended March 2026 as against Rs 265.28 crore during the previous quarter ended March 2025.

For the full year,net profit rose 22.98% to Rs 149.87 crore in the year ended March 2026 as against Rs 121.87 crore during the previous year ended March 2025. Sales rose 10.16% to Rs 1129.29 crore in the year ended March 2026 as against Rs 1025.09 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales282.95265.28 7 1129.291025.09 10
OPM %19.6316.19 -19.5418.06 -
PBDT58.1144.18 32 224.00188.76 19
PBT51.9437.72 38 203.31164.90 23
NP38.2529.58 29 149.87121.87 23